Global Medical REIT Inc. (NYSE:GMRE) Files An 8-K Regulation FD Disclosure
Item 7.01
On December 13, 2018, Global Medical REIT Inc. (the “Company”) filed with the Securities and Exchange Commission aprospectus supplement(the “Prospectus Supplement”) to the Company’sshelf registration statement on Form S-3 (Registration No. 333-217360), registering 1,000,000 shares of the Company’s common stock to be offered to the Company’sDividend Reinvestmentand Direct Stock Purchase Plan. A copy of the press release announcing the Company’s Dividend Reinvestmentand Direct Stock Purchase Plan and the dividends disclosed in Item 8.01 below is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.
Attached as Exhibit 5.1 to this Current Report is a copy of the opinion of Venable LLP regarding certain Maryland law matters, including the validity of the common stock offered to the Prospectus Supplement. Attached as Exhibit 8.1 to this Current Report is a copy of the opinion of Vinson& Elkins L.L.P. regarding certain tax matters in connection with the Prospectus Supplement.
The information in Exhibit99.1 referenced in Item 9.01 below is being “furnished” and, as such, shall not be deemed to be “filed” for the purposes of Section18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Sectionand shall not be incorporated by reference into any registration statement or other document filed by the Company to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
On December 13, 2018, the Company announced the declaration of:
| · | a cash dividend for the fourth quarter of 2018 of $0.20 per share of common stock to stockholders of record as of December 26, 2018, to be paid on January 10, 2019; and |
| · | a cash dividend of $0.46875 per share to holders of its Series A Cumulative Redeemable Preferred Stock, $0.001 par value per share (the “Series A Preferred Stock”), of record as of January 15, 2019, to be paid on January 31, 2019. This dividend represents the Company’s quarterly dividend on its Series A Preferred Stock for the period from October 31, 2018 through January 30, 2019. |
| Item 9.01 | Financial Statements and Exhibits. |
Global Medical REIT Inc. Exhibit
EX-5.1 2 tv509071_ex5-1.htm EXHIBIT 5.1 Exhibit 5.1 [LETTERHEAD OF VENABLE LLP] December 13,…
To view the full exhibit click here
About Global Medical REIT Inc. (NYSE:GMRE)
Global Medical REIT Inc. focuses on operating as a real estate investment trust. The Company is engaged primarily in the acquisition and leasing of licensed purpose-built healthcare facilities in certain markets with various clinical operators. The Company seeks to invest in these purpose-built, specialized facilities, such as surgery centers, specialty hospitals and outpatient treatment centers. Its tenant-operators are physician group tenant-operators, community hospital tenant-operators and corporate medical treatment chain operators. Its properties include a six building, 52,266 square foot medical clinic portfolio in Tennessee; a combined approximately 27,190 square foot surgery center and medical office building located in West Mifflin, Pennsylvania; an approximately 8,840 square foot medical office building known as the Orthopedic Surgery Center, located in Asheville, North Carolina, and a 56-bed long term acute care hospital located at 1870 South 75th Street, Omaha, Nebraska.
